Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
... the presence of a virus' RNA from a patient's
nasal or nasopharyngeal specimen. The S-OIV virus ... specimens, such as nasopharyngeal swabs,
nasal secretions,
nasal wash (lavage) and aspirations.
Public ...
Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
... the adjusted average symptom score on
nasal symptoms assessed during the
three last months of ... by 20% in both treated
groups. In particular, the
nasal congestion score has been improved by 40%
(median) and the
nasal pruritus by 32% (median). The safety profile has ...
Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
... was well and
reproducibly absorbed via the
nasal route with therapeutically relevant
plasma ... of administration. The
product showed good
nasal tolerability and systemic adverse effects ... difficult. IN
Apomorphine, an innovative aqueous
nasal spray formulation has been designed
to counter ...
PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
... studies of
PTC124 in adults with CF evaluated
nasal transepithelial potential
difference (TEPD) as a ... and in apical expression of CFTR protein in
nasal epithelium.
The study enrolled 30 children ages 6 ... chloride channel activity
as measured by
nasal potential difference, with 40 percent of ...
New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
... procedures
lowered the risk of blood loss in
nasal polypectomy/endoscopic sinus
surgery (ESS).
... alternative to microdebridement for patients
with
nasal polyps undergoing ESS as it resulted in better ... was a retrospective analysis of
25 patients with
nasal polyposis undergoing ESS and was conducted ...
Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
... a Phase II
equivalent study of MRX-4, in a
nasal aerosol formulation, in 105 patients
suffering ... rhinitis is characterized by
inflammation of the
nasal membranes accompanied by symptoms that may
include sneezing,
nasal ...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
... rhinitis is characterized by
inflammation of the
nasal membranes accompanied by symptoms that may
include sneezing,
nasal congestion,
nasal itching and rhinorrhea.
ABOUT MORRIA ...
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
... spray, saw significant improvement in daytime
nasal symptoms compared
to patients treated with Advair ... 100/50 twice daily
with fluticasone propionate
nasal spray 200 mcg once daily. Those who
received ... For best results, use Flonase daily. Your
nasal symptoms may begin to
improve in as few as 12 ...
ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
... is very
important, and we believe this novel
nasal formulation of ROX-828 may offer
a meaningful ... "Treating migraine with a potent NSAID in a
nasal spray is a sound
scientific approach," said Dr. ... common
side effects with ROX-828 were related to
nasal irritation.
The analgesic ketorolac has been ...
New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
... AQ (triamcinolone acetonide)
nasal Spray had no treatment effect
on stature-for age ... Rhinitis
Allergic rhinitis is a swelling of the
nasal passages, usually
accompanied by sneezing, watery
nasal discharge and itching of the nose and
eyes. This ...
Mayo Clinic Proceedings January Tip Sheet
... screening
and the safety and effectiveness of
nasal spray flu vaccine.
Mayo Researchers Examine ... Researchers Explore Safety and Effectiveness of
nasal Spray
Flu Vaccine
Influenza is a viral ... The flu vaccine -- available as an injection or
a
nasal spray -- offers protection against the flu. ...
Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
... rhinitis is characterized by
inflammation of the
nasal membranes accompanied by symptoms that may
include sneezing,
nasal congestion,
nasal itching and rhinorrhea.
ABOUT MORRIA ...
Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
... for its
Phase 2 clinical trial of PYY3-36
nasal Spray to treat obesity. The Company
enrolled 551 ... to evaluate three different doses of PYY3-36
nasal Spray
compared to placebo and sibutramine ... into the
Phase 2 study to evaluate PYY3-36
nasal spray as a novel treatment for
obesity. The fact ...
New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis
... more effective than placebo
in relieving overall
nasal allergy symptoms (nasal congestion, rhinorrhea,
sneezing and
nasal itching), the primary efficacy endpoint. Veramyst ... provided sustained,
24-hour efficacy for both
nasal and eye symptoms of perennial allergies. "This ...
Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
... to teriparatide (Parathyroid Hormone; PTH1-34)
nasal spray for the
treatment of osteoporosis from its ... and
commercialization agreement for PTH1-34
nasal Spray. Nastech will immediately advance PTH1-34
nasal Spray into a Phase 2
clinical study to evaluate ...
Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
... rhinitis is characterized by
inflammation of the
nasal membranes accompanied by symptoms that may
include sneezing,
nasal congestion,
nasal itching and rhinorrhea. ABOUT MORRIA ...
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
... 2 clinical
trial evaluating the Company's PYY3-36
nasal Spray in obese patients. The
study will enroll ... three different doses of
Nastech's PYY3-36
nasal Spray compared to placebo and ... the active PYY treatment
arms will take PYY3-36
nasal Spray ...
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
... - Rapid-Acting, Non-Invasive
nasal Spray Dosage form is Patient Friendly and ... study evaluating formulations of Insulin
nasal Spray
as compared to NovoLog(R) insulin aspart ... studies
demonstrated that the Company's Insulin
nasal Spray achieved faster time to
maximum plasma ...
BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
... Methicillin-Resistant Staphylococcus Aureus from
nasal Specimens
SAN DIEGO, Sept. 11 ... aureus
(MRSA) from patients colonized in the
nasal passage. The BD GeneOhm StaphSR assay is a ... provides results
within two hours directly from
nasal swabs. The assay is easy to perform
and requires ...
Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
... Critical Development Milestone - Novel,
nasal Powder Vaccine Delivery Technology
IRVING, ... the animal toxicology studies of its
GelVac(TM)
nasal powder influenza vaccine, incorporating an H5N1 ... a phase I human safety study
of the GelVac(TM)
nasal powder H5N1 vaccine in late 2007. The ...
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
... tract infection, nausea, pain in the arms, legs or back, upset stomach and
nasal congestion.
"Our dedicated team at United Therapeutics looks forward ... tract infection, extremity pain, nausea, back pain, dyspepsia and
nasal congestion.
In rare instances, patients taking PDE5 inhibitors ...
Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
... relief. It also holds promise in multiple drug delivery options
including
nasal spray, transdermal patch, and pills. Data were presented
today at the ... achieve pain relief, and so could have the potential
to be delivered via
nasal spray, transdermal patch, or pill.
Leconotide was also compared ...
Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
... cover Phase I and II trials of its lead
candidate SASPject(TM) PT1.2 for
nasal decolonisation of MRSA and S. aureus.
PT1.2 is based on a new class of ... of kill". Phico envisages
developing a fast-acting, easily applicable
nasal gel which would combat both
hospital S. aureus infection and hospital and ...
Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
... Total Symptom Score (sneezing, rhinorrhea,
nasal pruritus,
nasal congestion, ocular pruritus and watery eyes), to
evaluate the onset of ... as asthmatic patients,
- Every individual symptom, and in particular on
nasal congestion and watery eyes. Oralair(R) Grasses is a pre-seasonal ...
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
... which is designed to deter misuse and abuse by intentional swallowing of excess quantities of tablets, intravenous injection of dissolved tablets and
nasal snorting of crushed tablets. The Acurox(R) Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review ...
Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
... clinical trial were headache, myalgia, nasopharyngitis, flushing, respiratory tract infection, extremity pain, nausea, back pain, dyspepsia and
nasal congestion.
In rare instances, patients taking PDE5 inhibitors (including tadalafil) reported a sudden decrease or loss of vision or hearing, or ...
DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
... a local effect on inflamed tissue. BDP has been marketed in the US and worldwide since the early 1970s as the active pharmaceutical ingredient in a
nasal spray and in a metered-dose inhaler for the treatment of patients with allergic rhinitis and asthma. orBec(R) is formulated for oral administration ...
PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
... formulations, and inhaled drug therapies. Based on PARI's 100-year history working with aerosols, PARI Pharma develops treatments for pulmonary and
nasal administration optimized with advanced delivery technologies, such as eFlow Technology. PARI Pharma partners with pharmaceutical companies to develop ...
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
... and the most commonly observed adverse reactions (incidence >= 5% and two-fold greater than placebo) were dizziness, dry mouth, fatigue,
nasal congestion, orthostatic hypotension, somnolence, tachycardia, and weight increased.
Weight gain was mild, and the overall mean weight increase ...
Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
... in the placebo group.
Tadalafil 5 mg was generally well-tolerated, and the most frequently reported adverse events were headache, dyspepsia and
nasal congestion. Three subjects in the tadalafil group discontinued their participation in the study due to adverse events.
About Cialis
...
Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
... the IPSS and PVR rates increased and Qmax decreased. In addition, the men experienced several new side effects, including dizziness (4.6 percent),
nasal congestion (3.2 percent) and ejaculatory dysfunction (3.6 percent) for those switching alpha blockers, and ejaculatory dysfunction (4.7 percent) and ...
Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
... begun in 2007 in elementary schools, was expanded to middle school and high school students in 2008. Students could get the vaccine either in
nasal spray or injection formats. In order to receive the vaccine, both students and parents had to sign permission slips.
"We have demonstrated that ...
Premier Research Announces Milestone New Drug Application
... which is designed to deter misuse and abuse by intentional swallowing of excess quantities of tablets, intravenous injection of dissolved tablets and
nasal snorting of crushed tablets.
The submission of the NDA for Acurox(R) Tablets adds to considerable and growing expertise of the company in the ...
STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
... pollen peaks:
- in poly- and mono-sensitized patients and asthmatic patients,
- on every individual symptom, and, in particular, on
nasal congestion
and watery eyes.
Oralair(R) Grasses is indicated as a pre- and coseasonal treatment:
treatment should be started four ...
ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
... had a statistically significant effect on the rapidity of response and on additional signs or symptoms of ocular allergy, including improvement in
nasal symptoms. There were no serious ocular adverse events reported in patients dosed with Bepreve.
About Bepreve(TM) (bepotastine ophthalmic ...
Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
... aches (2.1% vs. 0.4%).
In patients with type 2 diabetes side effects that occurred greater
than placebo were constipation (8.7% vs. 2.0%), inflamed
nasal passages and
throat (4.1% vs. 3.6%), indigestion (3.9% vs. 1.4%), low blood sugar (3.0%
vs. 2.3%), nausea (3.0% vs. 1.4%) and high blood pressure ...
Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
... of Multisource pharmaceutical products
including: bulk and unit-dose liquids and solids; coated, sustained-release
and controlled release tablets;
nasal sprays, cytotoxics and CII narcotics.
Roxane Laboratories, Inc., is a subsidiary of Boehringer Ingelheim
Corporation, based in Ridgefield, CT and a ...
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
... demonstrated in vivo
proof of concept. AR-2474 has been shown to be effective in eradicating
pathogens in preclinical models of skin infection and
nasal carriage.
Apart from the antibiotic programmes, Arpida has an innovative
antifungal therapy (TLT) which is in Phase III clinical trials in ...
Critical Pharmaceuticals Enter Sustained Release hGH Arena
... We are also in preclinical development with
sustained release Risperidone and, demonstrating the versatility of our
technology platform, a once-daily
nasal formulation of hGH."
About Critical Pharmaceuticals
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company
with proprietary drug ...
Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
... has achieved in vivo proof of concept.
AR-2474 has been shown to be effective in eradicating pathogens in
preclinical models of skin infection and
nasal carriage.
Apart from the antibiotic programmes, Arpida has an innovative
antifungal therapy (TLT) which is in Phase III clinical trials in ...